Business Wire

Asuragen Announces CE Mark of AmplideX ® SMA Plus Kit

Share

Asuragen, Inc., a molecular diagnostics company delivering easy-to-use products for complex testing in genetics and oncology, today announced CE Mark of the AmplideX® SMAPlus Kit*, an in vitro diagnostic assay to aid in the diagnosis of spinal muscular atrophy (SMA) and to identify asymptomatic carriers at risk of passing along the disease to their children. By quantifying SMN1 and SMN2 copy number, as well as detecting additional variants associated with “silent carrier” status and overall disease prognosis, the kit provides a single laboratory solution to address the unique needs of both diagnostic and screening applications.

SMA is a debilitating illness resulting from the deficient production of motor neurons in the central nervous system and is a leading genetic cause of infant death. The disease is associated with a loss of functional copies of the SMN1 gene and its severity is, largely, inversely correlated to the number of copies of SMN2. Recent studies have shown that detection of gene duplication variants in the SMN1 gene may identify “silent carriers” for the disease who may otherwise be undetected by raw copy number analysis. Furthermore, the detection of a unique SMN2 disease modifier variant suggests a milder disease phenotype and may influence patient management. Overall screening and diagnostic efforts have spiked following the recent recommendations by the American College of Obstetrics and Gynecology and the availability of novel treatments including nusinersen (Spinraza®, Biogen Idec) and onasemnogene abeparvovec-xioi (ZOLGENSMA®, Novartis).

“Our laboratory has many years of experience testing various methodologies for the quantification of SMN1 and SMN2, but the [AmplideX SMA Plus Kit] has now set the bar for speed and simplicity,” said Henny Lemmink, PhD, Clinical Laboratory Geneticist, Department of Genetics, UMC Groningen. “By incorporating reporting of silent carrier risk as well as SMN2 disease modifier presence all from the same reaction, there is no comparison on the market for getting so much information so quickly and promises to become the first choice in diagnosis and carrier screening of SMA.”

The AmplideX SMAPlus Kit* is the most comprehensive commercial offering available to support the diagnosis and carrier screening of SMA. The kit comes complete with all necessary controls, calibrators, and PCR mixes required to run the assay and features push-button, automated reporting of patient results via its AmplideX Reporter software. From just a single PCR reaction, the assay streamlines the reporting of SMN1 and SMN2 exon 7 information in less time and effort compared to current methodologies, requiring less than one hour of hands-on-time and four hours of total testing time. Similar to other products within the AmplideX product portfolio, the assay is optimized for use on the Applied Biosystems™ family of Genetic Analyzers and is compatible with a broad range of thermal cycling equipment.

“Given the emergence of novel treatments and interventions for SMA, the demand for fast and accurate test results is greater than ever,” said Matthew McManus, MD, PhD, president and CEO of Asuragen. “With the AmplideX SMA Plus Kit, laboratories how have a simple and scalable solution to deliver meaningful results in a fraction of the time compared to alternative methods.”

*CE-IVD for US export only.

About Asuragen

Asuragen is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. For more information, visit www.asuragen.com.

Contact information

Lynne Hohlfeld
SVP, Corporate Development and CFO
Asuragen, Inc.
T: 512.681.5200
lhohlfeld@asuragen.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

On the Occasion of UN World Cities Day, Urban 20 (U20) Engagement Group of the G20, Announces the Creation of a “Global Urban Resilience Fund” in Response to COVID-1930.10.2020 11:05:00 CETPress release

The Urban 20 (U20), a G20 Engagement Group, today announced that it is working to create a Global Urban Resilience Fund, the first fund of its type developed by cities, for cities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201030005112/en/ U20 Chair H.E. Fahd Al-Rasheed at the U20 Mayors Summit (Photo: AETOSWire) Speaking about the announcement U20 Chair, H.E. Fahd Al-Rasheed, President of the Royal Commission for Riyadh City, noted; “We have the opportunity right now to learn from the impact of COVID-19, to study how to build cities which are more resilient and agile. The cities of the U20 have taken the lead to develop a fund for city action to combat the pandemic and mitigate future urban shocks. The goal of the fund is to accelerate the transmission of new learning and ideas for a more secure future for all urban residents.” The Fund comes as a response to the findings of the U20 Special Working Group (SWG) on COVID

CGTN: Challenges, Goals and Proposals From Communique of China's Ruling Party Plenum30.10.2020 04:13:00 CETPress release

The 19th Central Committee of the Communist Party of China (CPC) concluded its fifth plenary session in Beijing on Thursday with the release of a communique. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029006395/en/ The 14th Five-Year Plan (FYP) (2021-2025) for National Economic and Social Development and the Long-Range Objectives Through the Year 2035 are the key topics of the communique. Here is a look at all the highlights from the communique of the meeting. Read the original article: here. Decisive success made in building a moderately prosperous society in all respects This year is the final year of China's 13th FYP period (2016-2020) and the communique highlighted that the implementation of the 13th FYP has been smooth. By adhering to the new development concept and unswervingly advancing reform and opening-up, great achievements have been made since the fourth plenary session, the communique said. During the pas

HKTDC Autumn Sourcing Week | ONLINE Opens in Nov30.10.2020 02:11:00 CETPress release

Hong Kong, while the COVID-19 outbreak continues to hamper global business activities, online sourcing has become the ultimate solution that makes trade transactions possible. Riding on the success of the debut Summer Sourcing Weeks | Go ONLINE, the HKTDC is organising its next online exhibition from 16-27 November, Autumn Sourcing Week | ONLINE (ASWO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029006379/en/ Autumn Sourcing Week | ONLINE (ASWO) (Graphic: HKTDC) Benjamin Chau, HKTDC Deputy Executive Director, said: “The uncertainties brought by the COVID-19 pandemic have led more small and medium-sized enterprises (SMEs) to focus on online promotions and operations, which has quickly become the ‘new normal’ for conducting business. Given that the pandemic has prevented buyers and exhibitors from meeting in person, the HKTDC has introduced online business matching to enable networking and deal-making.” Under the theme

Ergomotion Announces Opening of First Manufacturing Facility in North America29.10.2020 22:28:00 CETPress release

Ergomotion, part of the Keeson Technology Group and the largest manufacturer of adjustable bases worldwide, will open a 250,000 square foot manufacturing facility in Ciudad Juárez, Chihuahua, the company’s first assembly plant in North America. The expansion was fueled by the decision to increase product capabilities, oversee manufacturing functions, and ultimately to stay closer to Ergomotion’s customer base in the United States. “We see a prime opportunity with the North America expansion to enhance the customer service experience in the U.S.,” says Johnny Griggs, Chief Operating Officer at Ergomotion. “Our goal is to provide our partners with world class manufacturing and supply chain and to help grow and strengthen their business. We’re excited to partner with Ciudad Juárez to expand our manufacturing capabilities and make this project viable and successful.” Ergomotion is making a significant investment that will allow for the creation of 400 jobs, within the local economy. The Ju

IDEMIA Launches Converged Card to Enable Financial Inclusion with Identity and Payment Card Solution29.10.2020 17:45:00 CETPress release

IDEMIA, a global leader in identity and security solutions and the number one provider of driver’s licenses in the U.S., today announced the development of a Converged Card solution in partnership with Mastercard, allowing cardholders to safely and securely shop for everyday essentials. The solution will help bring more people into the formal economy in the U.S. who currently have limited or no access to financial services. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201029005916/en/ IDEMIA Launches Converged Card to Enable Financial Inclusion with Identity and Payment Card Solution (Photo: Business Wire) Converged Card1 is a state-issued driver’s license or identification with a payment credential. This card or digital application will support state-subsidized programs, including unemployment benefits, housing and utility assistance, and tax refunds, allowing the government to automatically reach people that need funding

Airship Named a Leader in the 2020 Gartner Magic Quadrant for Mobile Marketing Platforms29.10.2020 16:34:00 CETPress release

Customer engagement companyAirship today announced that it has been named a Leader by Gartner, Inc. in its 2020 Magic Quadrant for Mobile Marketing Platforms.1 Among 13 vendors evaluated, Airship was positioned highest in its ability to execute and furthest to the right for its completeness of vision for the second consecutive year. A complimentary copy of the report is available from Airship. “Airship’s long held global leadership in customer engagement is experiencing dramatic acceleration, as new mobile-first capabilities like Airship Journeys make it much simpler and more effective to grow customer lifetime value in the omnichannel era. I believe Airship’s latest innovations, as well as expansions to experimentation and commerce, are already recognized as major beneficial differentiators in comprehensive evaluations like Gartner’s Magic Quadrant and Critical Capabilities reports,” said Brett Caine, CEO and president, Airship. “As mobile becomes increasingly vital for brands and the

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom